These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. (+)-Cyanidanol-3 in the treatment of acute viral hepatitis: a randomized controlled trial. Schomerus H; Wiedmann KH; Dölle W; Peerenboom H; Strohmeyer G; Balzer K; Goebell H; Dürr HK; Bode C; Blum AL Hepatology; 1984; 4(2):331-5. PubMed ID: 6368355 [TBL] [Abstract][Full Text] [Related]
25. [Uridine diphosphate glucose in acute viral hepatitis]. Crispo C; Perruna F; Di Nicuolo G; Rosiello A Minerva Med; 1982 Feb; 73(5):187-90. PubMed ID: 7038553 [TBL] [Abstract][Full Text] [Related]
26. A double-blind clinical trial of kamalahar, an indigenous compound preparation, in acute viral hepatitis. Das DG Indian J Gastroenterol; 1993 Oct; 12(4):126-8. PubMed ID: 8270290 [TBL] [Abstract][Full Text] [Related]
27. Ribavirin in respiratory syncytial virus infection. A double blind placebo controlled trial is needed. Isaacs D; Moxon ER; Harvey D; Kovar I; Madeley CR; Richardson RJ; Levin M; Whitelaw A; Modi N Arch Dis Child; 1988 Aug; 63(8):986-90. PubMed ID: 3046516 [No Abstract] [Full Text] [Related]
28. Reciprocal changes in serum albumin and alpha-fetoprotein levels in the recovery course of acute viral hepatitis stimulated by glucagon and insulin therapy: analysis of a double blind controlled trial. Fujiwara K; Ogata I; Oka H Gastroenterol Jpn; 1989 Apr; 24(2):143-8. PubMed ID: 2472994 [TBL] [Abstract][Full Text] [Related]
29. [Action of 1-beta-D-ribofuranosyl, 1,2,4-triazol-3-carboxamide on the treatment of acute viral hepatitis]. Zuñiga CB; de Almeida C; Iervolino AC; Castro Ide O; Galvão PA AMB Rev Assoc Med Bras; 1974 Nov; 20(11):386-90. PubMed ID: 4615344 [No Abstract] [Full Text] [Related]
30. Effect of ribavirin on murine cytomegalovirus infection. Dowling JN; Postic B; Guevarra LO Antimicrob Agents Chemother; 1976 Nov; 10(5):809-13. PubMed ID: 188383 [TBL] [Abstract][Full Text] [Related]
31. Treatment of acute viral hepatitis with (+)-cyanidanol-3. Blum AL; Berthet P; Doelle W; Goebell H; Kortüm K; Pelloni S; Peter P; Poulsen H; Strohmeyer G; Tygstrup N Lancet; 1977 Dec; 2(8049):1153-5. PubMed ID: 73062 [TBL] [Abstract][Full Text] [Related]
32. Lack of effect of oral ribavirin in naturally occurring influenza A virus (H1N1) infection. Smith CB; Charette RP; Fox JP; Cooney MK; Hall CE J Infect Dis; 1980 May; 141(5):548-54. PubMed ID: 7373088 [TBL] [Abstract][Full Text] [Related]
33. Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease. Hall CB; McBride JT; Gala CL; Hildreth SW; Schnabel KC JAMA; 1985 Dec; 254(21):3047-51. PubMed ID: 3903239 [TBL] [Abstract][Full Text] [Related]
35. The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker. Spector SA; Kennedy C; McCutchan JA; Bozzette SA; Straube RG; Connor JD; Richman DD J Infect Dis; 1989 May; 159(5):822-8. PubMed ID: 2496173 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of vaccinia virus growth by the nucleoside analogue 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ribavirin). Katz E; Margalith E; Winer B J Gen Virol; 1976 Aug; 32(2):327-30. PubMed ID: 1018177 [TBL] [Abstract][Full Text] [Related]
37. A multi-centre double-blind controlled trial of glucagon and insulin therapy for severe acute hepatitis. Oka H; Fujiwara K; Okita K; Ishii H; Sakuma A Gastroenterol Jpn; 1989 Jun; 24(3):332-6. PubMed ID: 2663609 [TBL] [Abstract][Full Text] [Related]